oral forms show mixed results in chronic disease
10.1093/toxsci/kfp093
Commercial pilots face stricter requirements than private pilots
Semaglutide, originally developed as a treatment for type 2 diabetes and now widely recognized for its role in weight management, is showing promise in another crucial area: potential cancer risk reduction
An injectable supramolecular nanofiber hydrogel (PA-GLP-1) has demonstrated sustained GLP-1 release for over 40 days and achieved blood glucose reduction and weight control outcomes comparable to daily semaglutide in a rat model of T2DM induced by STZ and nicotinamide (NA) [209]
Diets rich in fruits, vegetables, whole grains, and omega-3 polyunsaturated fatty acids (PUFAs) have been associated with a reduced risk of endometriosis and improved symptom control [74,75,76,77,78,79]